A breaking strategy for topoisomerase IIβ/PARP-1-dependent regulated transcription

被引:47
|
作者
Ju, Bong-Gun [1 ]
Rosenfeld, Michael G. [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Mol Med, La Jolla, CA 92093 USA
关键词
transcription; tortional stress; DSB; topoisomerase II; PARP-1; DNA-PK; nuclear matrix;
D O I
10.4161/cc.5.22.3497
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
While diverse enzymatic activities are required for transcriptional initiation, a central question remains whether additional enzymatic activities involved in other cellular processes may also be critical for regulated gene activation. Recently, we reported that signal-dependent activation of gene transcription requires topoisomerase II beta ( Topo II beta)-dependent, nucleosome-specific, transient double-stranded DNA break formation with subsequent activation of poly( ADP-ribose) polymerase-1 (PARP-1) enzymatic function, which causes local changes of chromatin architecture (Ju et al., Science 2006; 312: 1798-802). Here, we discussed that possible molecular mechanism underling Topo II beta/PARP-1/DNA-PK network in transcriptional initiation and many intriguing issues remain to be solved in the future.
引用
收藏
页码:2557 / 2560
页数:4
相关论文
共 50 条
  • [1] PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin
    Mouly, Laetitia
    Mamouni, Kenza
    Gence, Remi
    Cristini, Agnese
    Cherier, Julia
    Castinel, Adrien
    Legrand, Morgane
    Favre, Gilles
    Sordet, Olivier
    Monferran, Sylvie
    CELL DEATH & DISEASE, 2018, 9
  • [2] PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin
    Laetitia Mouly
    Kenza Mamouni
    Remi Gence
    Agnese Cristini
    Julia Cherier
    Adrien Castinel
    Morgane Legrand
    Gilles Favre
    Olivier Sordet
    Sylvie Monferran
    Cell Death & Disease, 9
  • [3] Transcription of carbonyl reductase 1 is regulated by DNA topoisomerase II beta
    Khazeem, Mushtaq M.
    Cowell, Ian G.
    Harkin, Lauren F.
    Casement, John W.
    Austin, Caroline A.
    FEBS LETTERS, 2020, 594 (20) : 3395 - 3405
  • [4] PARP-1-dependent 3-nitrotyrosine protein modification after DNA damage
    Siles, E
    Martinez-Lara, E
    Núñez, MI
    Muñoz-Gámez, JA
    Martín-Oliva, D
    Valenzuela, MT
    Peinado, MA
    de Almodóvar, JMR
    Oliver, FJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 96 (04) : 709 - 715
  • [5] A topoisomerase IIβ-mediated dsDNA break required for regulated transcription
    Ju, BG
    Lunyak, VV
    Perissi, V
    Garcia-Bassets, I
    Rose, DW
    Glass, CK
    Rosenfeld, MG
    SCIENCE, 2006, 312 (5781) : 1798 - 1802
  • [6] Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos)
    Wang, Yingfei
    Kim, No S.
    Li, Xiaoling
    Greer, Peter A.
    Koehler, Raymond C.
    Dawson, Valina L.
    Dawson, Ted M.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (02) : 687 - 696
  • [7] Charon Mediates Immune Deficiency-Driven PARP-1-Dependent Immune Responses in Drosophila
    Ji, Yingbiao
    Thomas, Colin
    Tulin, Nikita
    Lodhi, Niraj
    Boamah, Ernest
    Kolenko, Vladimir
    Tulin, Alexei V.
    JOURNAL OF IMMUNOLOGY, 2016, 197 (06): : 2382 - 2389
  • [8] Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation
    Chiu, Haw-Jyh
    Fischman, Donald A.
    Hammerling, Ulrich
    FASEB JOURNAL, 2008, 22 (11): : 3878 - 3887
  • [9] Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism
    Mohamed, Junaith S.
    Wilson, Joseph C.
    Myers, Matthew J.
    Sisson, Kayla J.
    Alway, Stephen E.
    AGING-US, 2014, 6 (10): : 820 - 834
  • [10] Saxagliptin protects against diabetic nephropathy by inhibiting caspase 3/PARP-1-dependent nephrocyte apoptosis
    Xing, Xiaowei
    Guo, Shuang
    Liu, Yusheng
    Kuang, Jiangying
    Huang, Zhiwei
    Wang, Xin
    Lu, Qinghua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)